These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 2580092)
1. Significance of antikeratin antibodies in rheumatoid arthritis. Hajiroussou VJ; Skingle J; Gillett AP; Webley M J Rheumatol; 1985 Feb; 12(1):57-9. PubMed ID: 2580092 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of antikeratin antibodies in rheumatoid arthritis. Ordeig J; Guardia J J Rheumatol; 1984 Oct; 11(5):602-4. PubMed ID: 6210364 [TBL] [Abstract][Full Text] [Related]
3. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940 [TBL] [Abstract][Full Text] [Related]
4. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection. Kessel A; Rosner I; Zuckerman E; Golan TD; Toubi E J Rheumatol; 2000 Mar; 27(3):610-2. PubMed ID: 10743797 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis. A clinical, serologic, and immunogenetic study. Boki KA; Kurki P; Holthofer H; Tzioufas AG; Drosos AA; Moutsopoulos HM J Rheumatol; 1995 Nov; 22(11):2046-8. PubMed ID: 8596142 [TBL] [Abstract][Full Text] [Related]
6. Anti-keratin antibodies in rheumatoid arthritis: frequency and correlation with other features of the disease. Mallya RK; Young BJ; Pepys MB; Hamblin TJ; Mace BE; Hamilton EB Clin Exp Immunol; 1983 Jan; 51(1):17-20. PubMed ID: 6187504 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis. Vasiliauskiene L; Wiik A; Høier-Madsen M Ann Rheum Dis; 2001 May; 60(5):459-66. PubMed ID: 11302867 [TBL] [Abstract][Full Text] [Related]
9. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis]. Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821 [TBL] [Abstract][Full Text] [Related]
10. How useful are tests for rheumatoid factors, antiperinuclear factors, antikeratin antibody, and the HLA DR4 antigen for the diagnosis of rheumatoid arthritis? Saraux A; Valls I; Voisin V; Koreichi A; Baron D; Youinou P; Le Goff P Rev Rhum Engl Ed; 1995 Jan; 62(1):16-20. PubMed ID: 7540486 [TBL] [Abstract][Full Text] [Related]
11. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis]. Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426 [TBL] [Abstract][Full Text] [Related]
12. [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis]. Youinou P; Le Goff P; Miossec P; Moineau MP; Ferec C Z Rheumatol; 1983; 42(1):36-9. PubMed ID: 6189305 [No Abstract] [Full Text] [Related]
13. Clinical relevance of antikeratin antibodies in rheumatoid arthritis and symmetric polyarthritis associated with hepatitis C infection. Cojocaru M; Cojocaru IM; Iacob SA Rom J Intern Med; 2004; 42(4):709-14. PubMed ID: 16366142 [TBL] [Abstract][Full Text] [Related]
14. Antikeratin antibodies in rheumatoid arthritis. Methods and clinical significance. Kirstein H; Mathiesen FK Scand J Rheumatol; 1987; 16(5):331-8. PubMed ID: 2446384 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Cordonnier C; Meyer O; Palazzo E; de Bandt M; Elias A; Nicaise P; Haïm T; Kahn MF; Chatellier G Br J Rheumatol; 1996 Jul; 35(7):620-4. PubMed ID: 8670593 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis? Salvador G; Gomez A; Vinas O; Ercilla G; Canete JD; Munoz-Gomez J; Sanmarti R Rheumatology (Oxford); 2003 Aug; 42(8):972-5. PubMed ID: 12730510 [TBL] [Abstract][Full Text] [Related]
17. Prospect for an additional laboratory criterion for rheumatoid arthritis. von Essen R; Kurki P; Isomäki H; Okubo S; Kautiainen H; Aho K Scand J Rheumatol; 1993; 22(6):267-72. PubMed ID: 7505480 [TBL] [Abstract][Full Text] [Related]
18. Immune deposits in the skin of patients with rheumatoid arthritis. McGill PE; Brougham PA; Tulloch J J Rheumatol; 1984 Aug; 11(4):454-6. PubMed ID: 6384506 [TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of antikeratin antibodies in rheumatoid arthritis. Miossec P; Youinou P; Le Goff P; Moineau MP Clin Rheumatol; 1982 Sep; 1(3):185-9. PubMed ID: 6205812 [TBL] [Abstract][Full Text] [Related]
20. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis. Johnson GD; Carvalho A; Holborow EJ; Goddard DH; Russell G Ann Rheum Dis; 1981 Jun; 40(3):263-6. PubMed ID: 6166255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]